The lawsuits involving Invokana state the manufacturer failed to warn patients and physicians of the increased risks of kidney failure, myocardial infarction (heart attacks), and ketoacidosis.
Plaintiffs attorneys argue that if the manufacturer had properly warned, then doctors would have prescribed a medication other than Invokana for patients with type 2 diabetes, and certainly patients would have had their health monitored on a more frequent basis for potential signs of heart issues, renal impairment, and high level of ketones.
Invokana linked to kidney disease, heart attacks and ketoacidosis
FDA and Scientific Studies Involving Invokana
DA strengthens kidney warnings for diabetes medicines Invokana, Invokamet, Farxiga & Xigduo XR
“The U.S. Food and Drug Administration (FDA) has strengthened the existing warning about the risk of acute kidney injury for the type 2 diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR).” To read more, click FDA Drug Safety
FDA revises labels of SGLT2 inhibitors [including Invokana] to include warnings about too much acid in the blood and serious urinary tract infections
“Patients should stop taking their SGLT2 inhibitor [such as Invokana] and seek medical attention immediately if they have any symptoms of ketoacidosis, a serious condition in which the body produces high levels of blood acids called ketones.” To read more, click FDA Drug Safety
What are the possible side effect of Invokana
- Kidney Failure
- Heart Attacks
DO I QUALIFY FOR AN INVOKANA LAWSUIT?
Anyone who has been diagnosed with ketoacidosis or suffered kidney injury after taking Invokana may qualify for a case. Simply contact DrugNews to learn more and talk to a lawyer today.